ISI Group Initiates Core Laboratories With Buy
Analysts at ISI Group initiated coverage on Core Laboratories N.V. (NYSE: CLB) with a Buy rating.
The target price for Core Laboratories is set to $151.
Core Laboratories shares have declined 27.02% over the past 52 weeks, while the S&P 500 index has surged 7.46% in the same period.
Core Laboratories' shares gained 3.63% to close at $138.56 yesterday.
Latest Ratings for CLB
Date | Firm | Action | From | To |
---|---|---|---|---|
Dec 2020 | JP Morgan | Downgrades | Neutral | Underweight |
Nov 2020 | Morgan Stanley | Upgrades | Equal-Weight | Overweight |
Oct 2020 | Morgan Stanley | Maintains | Equal-Weight |
View More Analyst Ratings for CLB
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: ISI GroupInitiation Analyst Ratings